Search Results - "Hakoum, Maram B"

Public health journals' requirements for authors to disclose funding and conflicts of interest: a cross-sectional study by Daou, Karim N, Hakoum, Maram B, Khamis, Assem M, Bou-Karroum, Lama, Ali, Ahmed, Habib, Joseph R, Semaan, Aline T, Guyatt, Gordon, Akl, Elie A

“…Public health journals need to have clear policies for reporting the funding of studies and authors' personal financial and non-financial conflicts of interest…”
Get full text

Reporting of conflicts of interest by authors of primary studies on health policy and systems research: a cross-sectional survey by Hakoum, Maram B, Bou-Karroum, Lama, Al-Gibbawi, Mounir, Khamis, Assem M, Raslan, Abdul Sattar, Badour, Sanaa, Agarwal, Arnav, Alturki, Fadel, Guyatt, Gordon, El-Jardali, Fadi, Akl, Elie A

“…ObjectivesThe objective of this study was to assess the frequency and types of conflict of interest (COI) disclosed by authors of primary studies of health…”
Get full text

The reporting of funding in health policy and systems research: a cross-sectional study by Khamis, Assem M, Bou-Karroum, Lama, Hakoum, Maram B, Al-Gibbawi, Mounir, Habib, Joseph R, El-Jardali, Fadi, Akl, Elie A

“…Major research-reporting statements, such as PRISMA and CONSORT, require authors to provide information about funding. The objectives of this study were (1) to…”
Get full text

Requirements of health policy and services journals for authors to disclose financial and non-financial conflicts of interest: a cross-sectional study by Khamis, Assem M, Hakoum, Maram B, Bou-Karroum, Lama, Habib, Joseph R, Ali, Ahmed, Guyatt, Gordon, El-Jardali, Fadi, Akl, Elie A

“…The requirements of the health policy and services journals for authors to report their financial and non-financial conflicts of interest (COI) are unclear…”
Get full text

Reporting of Financial and Non-financial Conflicts of Interest in Systematic Reviews on Health Policy and Systems Research: A Cross Sectional Survey by Bou-Karroum, Lama, Hakoum, Maram B, Hammoud, Mira Z, Khamis, Assem M, Al-Gibbawi, Mounir, Badour, Sanaa, Justina Hasbani, Divina, Cruz Lopes, Luciane, El-Rayess, Hebah M, El-Jardali, Fadi, Guyatt, Gordon, Akl, Elie A

“…Systematic reviews are increasingly used to inform health policy-making. The conflicts of interest (COI) of the authors of systematic reviews may bias their…”
Get full text

Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer by Kahale, Lara A, Hakoum, Maram B, Tsolakian, Ibrahim G, Matar, Charbel F, Terrenato, Irene, Sperati, Francesca, Barba, Maddalena, Yosuico, Victor Ed, Schünemann, Holger, Akl, Elie A

“…Cancer increases the risk of thromboembolic events, especially in people receiving anticoagulation treatments. To compare the efficacy and safety of low…”
Get more information

Anticoagulation for people with cancer and central venous catheters by Kahale, Lara A, Tsolakian, Ibrahim G, Hakoum, Maram B, Matar, Charbel F, Barba, Maddalena, Yosuico, Victor Ed, Terrenato, Irene, Sperati, Francesca, Schünemann, Holger, Akl, Elie A

“…Central venous catheter (CVC) placement increases the risk of thrombosis in people with cancer. Thrombosis often necessitates the removal of the CVC, resulting…”
Get more information

Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents by Kahale, Lara A, Matar, Charbel F, Tsolakian, Ibrahim, Hakoum, Maram B, Yosuico, Victor Ed, Terrenato, Irene, Sperati, Francesca, Barba, Maddalena, Hicks, Lisa K, Schünemann, Holger, Akl, Elie A

“…Multiple myeloma is a malignant plasma cell disorder characterised by clonal plasma cells that cause end-organ damage such as renal failure, lytic bone…”
Get more information

Parenteral anticoagulation in ambulatory patients with cancer by Akl, Elie A, Kahale, Lara A, Hakoum, Maram B, Matar, Charbel F, Sperati, Francesca, Barba, Maddalena, Yosuico, Victor E D, Terrenato, Irene, Synnot, Anneliese, Schünemann, Holger

“…Anticoagulation may improve survival in patients with cancer through a speculated anti-tumour effect, in addition to the antithrombotic effect, although may…”
Get more information

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation by Kahale, Lara A, Matar, Charbel F, Tsolakian, Ibrahim, Hakoum, Maram B, Barba, Maddalena, Yosuico, Victor Ed, Terrenato, Irene, Sperati, Francesca, Schünemann, Holger, Akl, Elie A

“…Oral anticoagulants may improve the survival of people with cancer through an antithrombotic effect, yet increase the risk of bleeding. To evaluate the…”
Get more information

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer by Kahale, Lara A, Matar, Charbel F, Hakoum, Maram B, Tsolakian, Ibrahim G, Yosuico, Victor Ed, Terrenato, Irene, Sperati, Francesca, Barba, Maddalena, Schünemann, Holger, Akl, Elie A

“…Compared with people without cancer, people with cancer who receive anticoagulant treatment for venous thromboembolism (VTE) are more likely to develop…”
Get more information

Anticoagulation for perioperative thromboprophylaxis in people with cancer by Matar, Charbel F, Kahale, Lara A, Hakoum, Maram B, Tsolakian, Ibrahim G, Etxeandia-Ikobaltzeta, Itziar, Yosuico, Victor Ed, Terrenato, Irene, Sperati, Francesca, Barba, Maddalena, Schünemann, Holger, Akl, Elie A

“…The choice of the appropriate perioperative thromboprophylaxis for people with cancer depends on the relative benefits and harms of different anticoagulants…”
Get more information

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer by Hakoum, Maram B, Kahale, Lara A, Tsolakian, Ibrahim G, Matar, Charbel F, Yosuico, Victor Ed, Terrenato, Irene, Sperati, Francesca, Barba, Maddalena, Schünemann, Holger, Akl, Elie A

“…Compared with people without cancer, people with cancer who receive anticoagulant treatment for venous thromboembolism (VTE) are more likely to develop…”
Get more information

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation by Kahale, Lara A, Hakoum, Maram B, Tsolakian, Ibrahim G, Matar, Charbel F, Barba, Maddalena, Yosuico, Victor E D, Terrenato, Irene, Sperati, Francesca, Schünemann, Holger, Akl, Elie A

“…Oral anticoagulants may improve the survival of people with cancer through both an antitumor effect and antithrombotic effect, yet increase the risk of…”
Get more information

Reporting of financial and non-financial conflicts of interest by authors of systematic reviews: a methodological survey by Hakoum, Maram B, Anouti, Sirine, Al-Gibbawi, Mounir, Abou-Jaoude, Elias A, Hasbani, Divina Justina, Lopes, Luciane Cruz, Agarwal, Arnav, Guyatt, Gordon, Akl, Elie A

“…BackgroundConflicts of interest may bias the findings of systematic reviews. The objective of this methodological survey was to assess the frequency and…”
Get full text

Authors of clinical trials seldom reported details when declaring their individual and institutional financial conflicts of interest: a cross-sectional survey by Hakoum, Maram B., Noureldine, Hussein, Habib, Joseph R., Abou-Jaoude, Eliane A., Raslan, Rasha, Jouni, Nahla, Hasbani, Divina Justina, Lopes, Luciane Cruz, Guyatt, Gordon, Akl, Elie A.

“…The main objective of this study was to document details of both individual and institutional financial conflicts of interest (FCOIs) reported by the authors…”
Get full text

Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance by Hakoum, Maram B, Jouni, Nahla, Abou-Jaoude, Eliane A, Hasbani, Divina Justina, Abou-Jaoude, Elias A, Lopes, Luciane Cruz, Khaldieh, Mariam, Hammoud, Mira Zein, Al-Gibbawi, Mounir, Anouti, Sirine, Guyatt, Gordon, Akl, Elie A

“…ObjectivesTo provide a detailed and current characterisation of funding of a representative sample clinical trials. We also aimed to develop guidance for…”
Get full text

Authors of clinical trials reported individual and financial conflicts of interest more frequently than institutional and nonfinancial ones: a methodological survey by Hakoum, Maram B., Jouni, Nahla, Abou-Jaoude, Eliane A., Hasbani, Divina Justina, Abou-Jaoude, Elias A., Lopes, Luciane Cruz, Khaldieh, Mariam, Hammoud, Mira Z., Al-Gibbawi, Mounir, Anouti, Sirine, Guyatt, Gordon, Akl, Elie A.

“…Conflicts of interest (COIs) are increasingly recognized as important to disclose and manage in health research. The objective of this study was to assess the…”
Get full text

Authors of Clinical Trials Reported Individual and Financial Conflicts of Interest More Frequently than Institutional and non-financial Ones: a Methodological Survey by Hakoum, Maram B., MD, Jouni, Nahla, BS, Abou-Jaoude, Eliane A., MD, Hasbani, Divina Justina, BS, Abou-Jaoude, Elias A., MBA, Lopes, Luciane Cruz, PhD, Khaldieh, Mariam, BS, Hammoud, Mira Z., MD, Al Gibbawi, Mounir, BS, Anouti, Sirine, MPH, Guyatt, Gordon, MD, MSc, Akl, Elie A., MD, MPH, PhD

“…Abstract Background Conflicts of interest (COI) are increasingly recognised as important to disclose and manage in health research. The objective of this study…”
Get full text